Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

Name: Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)
License: Public Domain

Wellstat Therapeutics

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

type 2 diabetes mellitus

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 325276
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.